Shopping Cart 0
Cart Subtotal
USD 0

Serum Institute of India Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Serum Institute of India Ltd (Serum Institute) is a biotechnology company that manufactures and markets vaccines and immuno-biologicals. The company offers products such as bacterial vaccines, viral vaccines, recombinant and combination vaccines, polysaccharide conjugate vaccines, meningococcal A conjugate vaccine, pharma products, anti cancer products and anti sera, plasma and influenza vaccines, among others. Its technological advancement include robotic arm for virus handling, cell factory and cell cube for growing cells, facilities for the manufacture of polysaccharide and recombinant vaccines and for monoclonal antibodies. Serum Institute utilizes latest technology screeners to inspect its products for any minute particulate matter undetectable to the normal human eye. It has operations in Chennai, Kolkatta, New Delhi, Surat, Trivandrum and Visakhapatnam. Serum Institute is headquartered in Pune, Maharashtra, India.

Serum Institute of India Ltd-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Serum Institute of India Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Serum Institute of India Ltd, Medical Devices Deals, 2012 to YTD 2018 9

Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deal Details 12

Asset Purchase 12

Serum Institute of India Acquires Production Facilities Of Netherlands Vaccine Institute For USD 40 Million 12

Venture Financing 13

Visterra Raises Additional USD23.6 Million in Series C Financing 13

Private Equity 15

Serum Institute Plans to Sell Minority Stake in Itself 15

Partnerships 16

Serum Institute of India Enters into Licensing Agreement with St. Jude Children's Research Hospital 16

IAVI and Serum Institute of India Enter into Development Partnership 17

Panacea Biotec Enters into Agreement with Serum Institute of India 18

Cipla Enters into Distribution Agreement with Serum Institute 19

Cipla Enters into Distribution Agreement with Serum Institute of India 20

Licensing Agreements 21

Serum Institute of India Enters into Licensing Agreement with Visterra 21

Serum Institute Expands Licensing Agreement with Genkyotex 22

Genticel Enters into Licensing Agreement with Serum Institute of India 23

Serum Institute of India Enters into Licensing Agreement with NeuClone 24

Nanolek Enters into Licensing Agreement with Bilthoven Biologicals for IPV Vaccine 25

Serum Institute of India Enters Into Licensing Agreement With Vakzine Projekt Management For VPM1002 26

Equity Offering 27

Xenetic Biosciences Raises USD0.3 Million in Private Placement of Shares 27

Acquisition 28

Serum Institute of India Acquires Nanotherapeutics for USD78.2 Million 28

Serum Institute Of India Acquires Bilthoven Biologicals, Monoclonal Antibodies And Vaccine Maker, For USD 101 Million 29

Serum Institute Plans To Sell Its Stake In Akorn 30

Serum Institute of India Ltd-Key Competitors 32

Serum Institute of India Ltd-Key Employees 33

Serum Institute of India Ltd-Locations And Subsidiaries 34

Head Office 34

Other Locations & Subsidiaries 34

Recent Developments 35

Product News 35

May 24, 2018: Serum Institute To Develop vaccine to fight Nipah Virus 35

Appendix 36

Methodology 36

About GlobalData 36

Contact Us 36

Disclaimer 36


List Of Figure

List of Figures

Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Serum Institute of India Ltd, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Key Facts 2

Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Serum Institute of India Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Serum Institute of India Ltd, Deals By Therapy Area, 2012 to YTD 2018 8

Serum Institute of India Ltd, Medical Devices Deals, 2012 to YTD 2018 9

Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Serum Institute of India Acquires Production Facilities Of Netherlands Vaccine Institute For USD 40 Million 12

Visterra Raises Additional USD23.6 Million in Series C Financing 13

Serum Institute Plans to Sell Minority Stake in Itself 15

Serum Institute of India Enters into Licensing Agreement with St. Jude Children's Research Hospital 16

IAVI and Serum Institute of India Enter into Development Partnership 17

Panacea Biotec Enters into Agreement with Serum Institute of India 18

Cipla Enters into Distribution Agreement with Serum Institute 19

Cipla Enters into Distribution Agreement with Serum Institute of India 20

Serum Institute of India Enters into Licensing Agreement with Visterra 21

Serum Institute Expands Licensing Agreement with Genkyotex 22

Genticel Enters into Licensing Agreement with Serum Institute of India 23

Serum Institute of India Enters into Licensing Agreement with NeuClone 24

Nanolek Enters into Licensing Agreement with Bilthoven Biologicals for IPV Vaccine 25

Serum Institute of India Enters Into Licensing Agreement With Vakzine Projekt Management For VPM1002 26

Xenetic Biosciences Raises USD0.3 Million in Private Placement of Shares 27

Serum Institute of India Acquires Nanotherapeutics for USD78.2 Million 28

Serum Institute Of India Acquires Bilthoven Biologicals, Monoclonal Antibodies And Vaccine Maker, For USD 101 Million 29

Serum Institute Plans To Sell Its Stake In Akorn 30

Serum Institute of India Ltd, Key Competitors 32

Serum Institute of India Ltd, Key Employees 33

Serum Institute of India Ltd, Other Locations 34

Serum Institute of India Ltd, Subsidiaries 34

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Serum Institute of India Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.